8-K: AudioEye CEO's Employment Agreement Extended with Salary Adjustment and Equity Grant

AudioEye extends CEO David Moradi's employment agreement, adjusts his salary to $1 annually, and grants him additional restricted stock units.

Summary

• AudioEye, Inc. has entered into a Second Amendment to the employment agreement with CEO David Moradi.
• The amendment extends the term of the agreement to January 9, 2027.
• Starting in the second quarter of 2025, Mr. Moradi's annual base salary will be $1.
• Mr. Moradi will receive a grant of 241,444 restricted stock units (RSUs) that vest on January 9, 2026 (81,444 RSUs) and January 9, 2027 (160,000 RSUs), contingent on his continued service.
• Unvested RSUs will fully vest upon termination without cause, death, or a change in control involving a corporate transaction.
• The performance period for certain performance share awards (PSAs) is extended to January 9, 2027.
• The Board of Directors has nominated the four other current directors of the Company for re-election as directors at the 2025 Annual Meeting of Stockholders of the Company.
• The Board of Directors also took action to reduce its size to four members, effective upon the expiration of Dr. Bettis term as a director at the 2025 Annual Meeting.
• Mr. Moradi will be appointed Chairman of the Board, effective on the date of the 2025 Annual Meeting.

Sentiment

Score: 7

Explanation: The announcement is generally positive, indicating stability in leadership and incentivizing the CEO. The reduction in salary is unusual but likely offset by the equity grant, suggesting a focus on long-term performance.

Positives

• The extension of the CEO's employment agreement provides stability in leadership.
• The RSU grant incentivizes the CEO to remain with the company and achieve long-term goals.
• The acceleration of RSU vesting upon certain events protects the CEO's interests.
• The extension of the performance period for PSAs gives the CEO more time to meet performance targets.
• The nomination of the four other current directors of the Company for re-election as directors at the 2025 Annual Meeting of Stockholders of the Company provides stability.
• The Board of Directors also took action to reduce its size to four members, effective upon the expiration of Dr. Bettis term as a director at the 2025 Annual Meeting.
• Mr. Moradi will be appointed Chairman of the Board, effective on the date of the 2025 Annual Meeting.

Negatives

• The reduction of the CEO's salary to $1 annually may raise concerns about his motivation, although it is likely offset by the equity grant.
• The termination of Dr. Bettis position as Executive Chairman of the Board will terminate, and the Executive Employment Agreement, dated as of July 1, 2015, between Dr. Bettis and Company will terminate, effective on the date of the 2025 Annual Meeting.

Risks

• Failure to meet the performance conditions for the PSAs by January 9, 2027, will result in forfeiture of those shares.
• The company's performance may be affected if the CEO does not remain with the company until the RSU vesting dates.
• The Board of Directors also took action to reduce its size to four members, effective upon the expiration of Dr. Bettis term as a director at the 2025 Annual Meeting.
• Mr. Moradi will be appointed Chairman of the Board, effective on the date of the 2025 Annual Meeting.

Future Outlook

The company aims to retain its CEO through January 9, 2027, incentivizing him with equity and extending the performance period for existing performance share awards.

Management Comments

• The document does not contain direct quotes, but it implies that the company values the CEO's contributions and wants to ensure his continued service.

Industry Context

Executive compensation structures often involve a mix of salary, equity, and performance-based incentives to align management's interests with those of shareholders. Reducing the base salary while increasing equity grants is a common strategy to emphasize long-term value creation.

Comparison to Industry Standards

• Executive compensation packages vary widely across industries and company sizes.
• Companies like Microsoft, Apple, and Google often use a combination of salary, stock options, and restricted stock units to compensate their top executives.
• The trend of reducing base salary and increasing equity grants is seen in many tech companies to incentivize long-term performance.
• The specific terms of the agreement, such as the vesting schedule and performance conditions, are tailored to the company's specific goals and circumstances.

Management Changes

Stakeholder Impact

• Shareholders may view the extension of the CEO's contract and equity grant positively, as it aligns management's interests with long-term value creation.
• Employees may be reassured by the stability in leadership.
• The changes in board composition could impact the company's strategic direction.

Next Steps

• Re-election of directors at the 2025 Annual Meeting of Stockholders.
• Appointment of Mr. Moradi as Chairman of the Board, effective on the date of the 2025 Annual Meeting.
• Vesting of RSUs on January 9, 2026 and January 9, 2027, contingent on continued service.
• Achievement of performance conditions for PSAs by January 9, 2027.

Key Dates

Keywords

employment agreement, CEO, David Moradi, restricted stock units, RSUs, performance share awards, PSAs, executive compensation, corporate governance, AudioEye